1-13 of 13
Mark Fiala
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Assay for Quantification of Free Light Chain (FLC) Dimers in Serum of Patients with Plasma Cell Dyscrasias

Mariya Liyasova, Michael Slade, Julie Fortier, Ravi Vij, Mark Fiala, Liqiang Yang, Bin Ma
Journal: Blood
Blood (2023) 142 (Supplement 1): 2292.
https://doi.org/10.1182/blood-2023-186583
Published: 2023
Journal Articles

Measurable Residual Disease Status By Clonotypic Mass Spectrometry with Easym Assay Predicts Outcomes Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma

Michael Slade, Abir Khaled, Mark Fiala, Zac McDonald, Mariya Liyasova, Julie Fortier, Mark Zaydman, Sarah Kelley, Zachary David Crees, Mark A. Schroeder, Keith Stockerl-Goldstein, Liqiang Yang, Ravi Vij
Journal: Blood
Blood (2023) 142 (Supplement 1): 3354.
https://doi.org/10.1182/blood-2023-172440
Published: 2023
Journal Articles

Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft

Mark A. Schroeder, Michael P. Rettig, Sandra Lopez, Stephanie Christ, Mark Fiala, William Eades, Fazia A. Mir, Jin Shao, Kyle McFarland, Kathryn Trinkaus, William Shannon, Elena Deych, Jinsheng Yu, Ravi Vij, Keith Stockerl-Goldstein, Amanda F. Cashen, Geoffrey L. Uy, Camille N. Abboud, Peter Westervelt, John F. DiPersio
Journal: Blood
Blood (2017) 129 (19): 2680–2692.
https://doi.org/10.1182/blood-2016-09-739722
Published: 2017
Includes: Supplemental data
Journal Articles

Whole Genome Sequencing Reveals Novel Recurring Somatic Mutations Affecting HUWE1 and DIAPH2 Genes in Multiple Myeloma

Michael H. Tomasson, MD, Dong Shen, PhD, Vishwanathan Hucthagowder, PhD, William Schierding, B.S., Chelsea D. Mullins, BSci, Mark Fiala, BS, CCRP, Ira M Hall, PhD, John Wallis, PhD, Robert S. Fulton, Lucinda A. Fulton, MS, Shashikant Kulkarni, PhD, Elaine R. Mardis, PhD, Richard K Wilson, Timothy J. Ley, John F. DiPersio, MD, PhD, Christopher A. Maher, PhD, Ravi Vij, MD, Li Ding
Journal: Blood
Blood (2012) 120 (21): 320.
https://doi.org/10.1182/blood.V120.21.320.320
Published: 2012
Journal Articles

Detection of Multiple Myeloma Cells in Peripheral Blood Using High-Throughput Sequencing Assay

Amitabha Mazumder, M.D., Malek Faham, MD, PhD, Mark Fiala, BS, CCRP, Mark Klinger, PhD, Thomas Martin, MD, Jeesun Park, B.A., Ravi Vij, MD, Jeffrey L Wolf, MD
Journal: Blood
Blood (2012) 120 (21): 321.
https://doi.org/10.1182/blood.V120.21.321.321
Published: 2012
Journal Articles

Genome-Wide Copy Number Analyses Correlated with Outcomes in Untreated Multiple Myeloma Patients

Vishwanathan Hucthagowder, PhD, Mark Fiala, BS, CCRP, Doug Cox, BS, Keith E. Stockerl-Goldstein, MD, Michael H. Tomasson, MD, John F. DiPersio, MD, PhD, Ravi Vij, MD, Shashikant Kulkarni, PhD
Journal: Blood
Blood (2012) 120 (21): 3991.
https://doi.org/10.1182/blood.V120.21.3991.3991
Published: 2012
Journal Articles

The Demographics and Outcomes of Patients with Multiple Myeloma Dual Refractory to or Intolerant of Bortezomib and Lenalidomide in the Era of Carfilzomib and Pomalidomide

Tzu-Fei Wang, MD, Mark Fiala, BS, CCRP, Rohan Ahluwalia, MD, Kathryn Trinkaus, PhD, Caitlin Moliske, Doug Cox, BS, Matthew Jaenicke, BS, Keith Stockerl-Goldstein, MD, Tanya Wildes, MD, Kenneth R. Carson, MD, Michael H. Tomasson, MD, Ravi Vij, MBBS, MD
Journal: Blood
Blood (2012) 120 (21): 4050.
https://doi.org/10.1182/blood.V120.21.4050.4050
Published: 2012
Journal Articles

Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of Bendamustine in Combination with Lenalidomide and Dexamethasone (BRD) in Patients with Relapsed Multiple Myeloma: A Multiple Myeloma Research Consortium Study.

Shaji K. Kumar, MD, Amrita Krishnan, MD, Vivek Roy, M.D., Todd M Zimmerman, MD, Morie Abraham A Gertz, MD, Keith E. Stockerl-Goldstein, MD, Francis K Buadi, M.D., Cara Rosenbaum, MD, Ann Birgin, CRA, Mark Fiala, BS, CCRP, Valeria Jiminez, Michele Maharaj, RN, Michael N. Needle, MD, Ravi Vij, MD
Journal: Blood
Blood (2012) 120 (21): 2965.
https://doi.org/10.1182/blood.V120.21.2965.2965
Published: 2012
Journal Articles

High Throughput Digital Quantification of Genomic Copy Number Alterations in Multiple Myeloma

Shashikant Kulkarni, PhD, Nathan Elliott, PhD, Mark Fiala, BS, Jacob Paasch, BS, Michael H. Tomasson, MD, Keith E. Stockerl-Goldstein, MD, John F. DiPersio, MD, PhD, Gary Geiss, PhD, Ravi Vij, MD, Vishwanathan Hucthagowder, PhD
Journal: Blood
Blood (2011) 118 (21): 1830.
https://doi.org/10.1182/blood.V118.21.1830.1830
Published: 2011
Journal Articles

Genomic Landscape of Immunoglobulin Light Chain (AL) Amyloidosis and Comparative Analyses with Related Malignant Plasma Cell Disorder- Multiple Myeloma

Vishwanathan Hucthagowder, PhD, Jahangheer Shaik, PhD, Mark Fiala, BS, Jacob Paasch, BS, Rakesh Nagarajan, MD, PhD, Keith E. Stockerl-Goldstein, MD, John F. DiPersio, MD, PhD, Michael H. Tomasson, MD, Ravi Vij, MD, Shashikant Kulkarni, PhD
Journal: Blood
Blood (2011) 118 (21): 809.
https://doi.org/10.1182/blood.V118.21.809.809
Published: 2011
Journal Articles

The Multiple Myeloma Research Consortium (MMRC): Accelerated Start up and Accrual Metrics Speeds Drug Development

Sandra M. Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MD, Mark Fiala, BS, Sagar Lonial, MD, Alaina R. Mitchell, BS, David S. Siegel, MD, PhD, Adolfo Aleman, CCRP, Andrzej J Jakubowiak, MD, PhD, Diane E Durecki, BA, Donna E. Reece, MD, FRCPC, Engin Gul, HonBSc, Ajai Chari, MD, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Mindy A Bowers, BS, A. Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Geraldine Pelle-Day, Ph.D., Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Daniel Larsen, BS, Shaji Kumar, MD, Ann Birgin, CRA, Noopur S. Raje, MD, Vivek Roy, M.D., Michele Maharaj, RN, Joseph W. Fay, MD, Tracey Messing, RN, Robert F Ott, MBA, Leah Tasca, BA, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2011) 118 (21): 1024.
https://doi.org/10.1182/blood.V118.21.1024.1024
Published: 2011
Journal Articles

The Multiple Myeloma Research Consortium (MMRC) Model: Reduced Time to Trial Activation and Improved Accrual Metrics.

Sandra Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MBBS, MD, Mark Fiala, BS, CCRP, Sagar Lonial, MD, Dixil Francis, MPH, CCRC, David Samuel diCapua Siegel, MD, PhD, Alex Schramm, BA, Andrzej J. Jakubowiak, MD, PhD, Colleen K. Harvey, Donna E. Reece, MD, Engin Gul, HonBSc, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Buffy Jansak, BSN, OCN, Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Beth Davis, Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Angela Cisneros, Shaji Kumar, MD, Ann Birgin, CRA, Robert Ott, MBA, Leah Tasca, Susan L. Kelley, MD, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2010) 116 (21): 3803.
https://doi.org/10.1182/blood.V116.21.3803.3803
Published: 2010
Journal Articles

A Single-Institution Randomized Prospective Trial of Pre-Emptive Therapy with Oral Valganciclovir Compared with IV Ganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplant (aHSCT), Delayed until Viral Load (VL) >10,000 Copies/Ml or >5,000 Copies/Ml X 2

James C Mosley, III, M.D., Linda Verkruyse, MD, PhD, Mark Fiala, B.S., Kim Trinkhaus, Ph.D., Camille N Abboud, MD, Amanda F Cashen, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Gregory A Storch, M.D., Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2008) 112 (11): 4340.
https://doi.org/10.1182/blood.V112.11.4340.4340
Published: 2008